Clinical Trial Update: Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy

View source ↗

Summary

This clinical trial update assesses whether ranolazine reduces myocardial ischemia detected by high-field 3T cardiovascular MRI and P-31 spectroscopy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Ischemic Heart Disease

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Westside Medical Associates of Los Angeles | Conditions: Angina, Heart Disease | Status: UNKNOWN